Compare ARK Genomic Revolution ETF (ARKG) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Illumina, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while Illumina, Inc. trades at $193.06 (market cap $29.12B). Which is the better fit depends on your goals.
| ARKG | ILMN | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $44.55 | $205.10 |
52-Week Low | $24.02 | $91.00 |
Market Cap | — | $29.12B |
Enterprise Value | — | $30.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
